Scott L Burrows insider trades

Open-market stock purchases and sales by Scott L Burrows, Chief Financial Officer at Spyre Therapeutics, Inc, from SEC Form 4 filings since Apr 1, 2021.

Recent trades

DateStockTradeValue
Sep 2, 2026SYRE Spyre Therapeutics, IncSold$1.6M
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$77.6K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$382K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$177K
Sep 1, 2026SYRE Spyre Therapeutics, IncSold$17.8K
Sep 1, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$486K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$221K
Aug 3, 2026SYRE Spyre Therapeutics, IncSold$9.7K
Aug 3, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
Jun 25, 2026SYRE Spyre Therapeutics, IncSold$436K
Jun 25, 2026SYRE Spyre Therapeutics, IncSold$871K
Jun 25, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$126K
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$184K
Jun 1, 2026SYRE Spyre Therapeutics, IncSold$223K
Jun 1, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
May 1, 2026SYRE Spyre Therapeutics, IncSold$892K
May 1, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
Apr 1, 2026SYRE Spyre Therapeutics, IncSold$305K
Apr 1, 2026SYRE Spyre Therapeutics, IncSold$65K
Apr 1, 2026SYRE Spyre Therapeutics, IncBought (not open market)—
Mar 3, 2026SYRE Spyre Therapeutics, IncSold$93.3K
Mar 3, 2026SYRE Spyre Therapeutics, IncSold$8.3K
Mar 3, 2026SYRE Spyre Therapeutics, IncBought (not open market)—

Companies traded

  • SYRE Spyre Therapeutics, Inc: 20 sales, last Sep 2, 2026
  • AGLE Aeglea BioTherapeutics, Inc: other filings, last Sep 1, 2023
  • ARQT Arcutis Biotherapeutics, Inc: 8 sales, last Mar 6, 2023

Get free alerts when Scott L Burrows files a new trade →